Bridgefront Capital, LLC Organon & Co. Transaction History
Bridgefront Capital, LLC
- $249 Million
- Q3 2024
A detailed history of Bridgefront Capital, LLC transactions in Organon & Co. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 19,535 shares of OGN stock, worth $311,973. This represents 0.15% of its overall portfolio holdings.
Number of Shares
19,535Holding current value
$311,973% of portfolio
0.15%Shares
3 transactions
Others Institutions Holding OGN
# of Institutions
789Shares Held
201MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$520 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$482 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$178 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$156 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$143 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.06B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...